Bill and Debbie Pappas

Bill and Debbie Pappas named UNC Lineberger as a beneficiary of one of their retirement plan accounts, a significant and meaningful gift that reflects their complementary perspectives.

Bill and Debbie Pappas

Bill and Debbie Pappas of Raleigh, NC, share the same vision—to stop the devastating impact of cancer—and are both profoundly committed to helping UNC Lineberger progress toward this goal. However, their passion for contributing to the cancer fight is rooted in different places.

Debbie draws her resolve from loved ones who cancer has taken too soon. “I lost some really close friends to cancer and because of them I got involved as a volunteer,” said Debbie. “I wanted to learn more and to be helpful to patients and families.”

As a lawyer, Bill has worked with a number of physicians, health care professionals and life sciences and biotechnology companies. These experiences have shown him the huge opportunities that exist for research to change the cancer conversation. “Although cancer has not affected our family, it affects almost every third person I have contact with somehow or another. Because of my background, I see the potential gain of cutting-edge research,” said Bill.

By naming UNC Lineberger as a beneficiary of one of their retirement plan accounts, they were able to make a significant and meaningful gift that reflects their complementary perspectives. “One side of our gift underscores the real value of the research side,” explained Bill. “Then, on the other side, both of us are very concerned about the way the hospital interfaces with patients—the people who are beneficiaries of that research and the wonderful technical
skills the hospital has.”

Recognizing that cancer is a multifaceted, pervasive disease, Bill and Debbie view their planned gift as an investment in future discoveries and progress. “Debbie and I think that by giving not only now, but also in the future with a planned gift, we are perpetuating the ability of the cancer center to do good things in treating and ultimately finding a cure for different kinds of cancer.”